Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB05265_nanopub.RASuWkbmagDwBk0_TnCkYZRrwDybguKsW2GYFF5bgEisc#assertion>. }
Showing items 1 to 18 of
18
with 100 items per page.
- drugbank:DB05265 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05265 label "Ecabet [drugbank:DB05265]" assertion.
- drugbank:DB05265 seeAlso ecabet-sodium.html assertion.
- drugbank:DB05265 seeAlso DB05265 assertion.
- drugbank:DB05265 description "Ecabet is a prescription eye drop for the treatment of dry eye syndrome. Ecabet represents a new class of molecules that increases the quantity and quality of mucin produced by conjunctival goblet cells and corneal epithelia. Mucin is a glycoprotein component of tear film that lubricates while retarding moisture loss from tear evaporation. Ecabet is currently marketed in Japan as an oral agent for treatment of gastric ulcers and gastritis." assertion.
- drugbank:DB05265 identifier "drugbank:DB05265" assertion.
- drugbank:DB05265 title "Ecabet" assertion.
- drugbank:DB05265 drugbank_vocabulary:x-pubchemsubstance pubchem.substance:99443230 assertion.
- drugbank:DB05265 drugbank_vocabulary:x-pubchemcompound pubchem.compound:65781 assertion.
- drugbank:DB05265 drugbank_vocabulary:x-chemspider chemspider:570992 assertion.
- drugbank:DB05265 drugbank_vocabulary:x-cas cas:33159-27-2 assertion.
- drugbank:DB05265 drugbank_vocabulary:drugbank-id "DB05265" assertion.
- drugbank:DB05265 bio2rdf_vocabulary:x-identifiers.org DB05265 assertion.
- drugbank:DB05265 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05265" assertion.
- drugbank:DB05265 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05265 bio2rdf_vocabulary:identifier "DB05265" assertion.
- drugbank:DB05265 drugbank_vocabulary:x-pharmgkb pharmgkb:PA165958350 assertion.
- drugbank:DB05265 drugbank_vocabulary:x-kegg kegg:D07885 assertion.